Becton Dickinson & Co (BDX)
225.15
-2.02
(-0.89%)
USD |
NYSE |
Nov 15, 16:00
225.19
+0.04
(+0.02%)
After-Hours: 20:00
Becton Dickinson Research and Development Expense (TTM): 1.19B for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.19B |
| June 30, 2024 | 1.169B |
| March 31, 2024 | 1.176B |
| December 31, 2023 | 1.214B |
| September 30, 2023 | 1.237B |
| June 30, 2023 | 1.256B |
| March 31, 2023 | 1.265B |
| December 31, 2022 | 1.255B |
| September 30, 2022 | 1.256B |
| June 30, 2022 | 1.324B |
| March 31, 2022 | 1.339B |
| December 31, 2021 | 1.329B |
| September 30, 2021 | 1.306B |
| June 30, 2021 | 1.18B |
| March 31, 2021 | 1.112B |
| December 31, 2020 | 1.059B |
| September 30, 2020 | 1.038B |
| June 30, 2020 | 1.066B |
| March 31, 2020 | 1.086B |
| December 31, 2019 | 1.074B |
| September 30, 2019 | 1.062B |
| June 30, 2019 | 1.069B |
| March 31, 2019 | 1.064B |
| December 31, 2018 | 1.071B |
| September 30, 2018 | 1.004B |
| Date | Value |
|---|---|
| June 30, 2018 | 943.00M |
| March 31, 2018 | 852.00M |
| December 31, 2017 | 780.00M |
| September 30, 2017 | 771.00M |
| June 30, 2017 | 808.00M |
| March 31, 2017 | 829.00M |
| December 31, 2016 | 824.00M |
| September 30, 2016 | 829.00M |
| June 30, 2016 | 772.00M |
| March 31, 2016 | 743.00M |
| December 31, 2015 | 690.00M |
| September 30, 2015 | 632.00M |
| June 30, 2015 | 576.00M |
| March 31, 2015 | 535.00M |
| December 31, 2014 | 553.00M |
| September 30, 2014 | 550.00M |
| June 30, 2014 | 542.00M |
| March 31, 2014 | 526.00M |
| December 31, 2013 | 501.00M |
| September 30, 2013 | 493.00M |
| June 30, 2013 | 489.03M |
| March 31, 2013 | 483.02M |
| December 31, 2012 | 477.77M |
| September 30, 2012 | 472.00M |
| June 30, 2012 | 468.98M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
1.038B
Minimum
Sep 2020
1.339B
Maximum
Mar 2022
1.197B
Average
1.202B
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp | 1.519B |
| Abbott Laboratories | 2.795B |
| Baxter International Inc | 754.00M |
| Merit Medical Systems Inc | 83.91M |
| ResMed Inc | 311.34M |